Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 6551–6600 of 75459
Effective June 30, 2025, David D. Kaiser, our Chief Credit Officer, will be retiring and relinquishing all positions he holds with Arrow Financial Corporation (“Arrow”) and its subsidiaries.
Craig W. Best, President of the Corporation and Farmers and Merchants Trust Company of Chambersburg (the “Bank”), will succeed Timothy G. Henry as Chief Executive Officer of the Corporation and the Bank on April 29, 2025 upon conclusion of the Corporation’s 2025 Annual Meeting.
Mr. Henry’s previously announced retirement date of April 29, 2025 has been extended to May 2, 2025.
On April 8, 2025, Christopher Wright notified Roper Technologies, Inc. (the “Company”) of his intention to retire from the Company’s Board of Directors, effective as of the Company’s 2025 Annual Meeting of Shareholders to be held on June 10, 2025.
On April 10, 2025, Ms. Luconi and the Company mutually agreed that her final date of employment will be May 2, 2025.
David H. Y. Ho, a member of the Board, notified the Company of his decision to resign from the Board.
the Board increased the size of the Board to 9 members and appointed Richard L. Clemmer and Chris Koopmans to the Board, effective immediately.
the Board increased the size of the Board to 9 members and appointed Richard L. Clemmer and Chris Koopmans to the Board, effective immediately.
John Freund, M.D., a member of the Board of Directors (the “Board”) of Sutro Biopharma, Inc., a Delaware corporation (the “Company”) since 2014, informed the Board of his decision to not stand for re-election to the Board.
On April 12, 2025, Gavin D.K. Hattersley, President and Chief Executive Officer of Molson Coors Beverage Company (the “Company”) and a member of the Company’s Board of Directors (the “Board”), informed the Company and the Board that he intends to retire from the Company and as a member of the Board, in each case, by December 31, 2025.
Pursuant to notice provided on April 8, 2025, Charles Remsberg’s employment as the Chief Sales Officer of the Company will be terminated, effective May 30, 2025.
Effective April 14, 2025, the Board appointed David McIntyre as Chief Financial Officer, principal financial officer and principal accounting officer of the Company (the “Appointment”).
Effective April 11, 2025, Garth Lees-Rolfe resigned as Chief Financial Officer, principal financial officer and principal accounting officer of Inhibikase Therapeutics, Inc. (the “Company”).
Michael H. Jenkins, the Company’s Chief Executive Officer, has been replaced as Chief Executive Officer of the Company (the “Termination Date”).
the Company also announced its Board’s appointment of Sally A. Washlow as the Company’s new Chief Executive Officer, effective as of Mr. Jenkins’ Termination Date.
On April 13, 2025, Raghib Hussain, President, Products and Technologies of Marvell Technology, Inc. (“Marvell”), notified Marvell of his decision to resign from his position with Marvell effective as of May 2, 2025, to become the Chief Executive Officer of another company.
On April 11, 2024, Blackstone Infrastructure Strategies Associates L.P., the general partner (the “General Partner”) of Blackstone Infrastructure Strategies L.P. (the “Fund”), and the Fund’s board of directors (the “Board”) appointed Susan Roth Katzke to the Board as an independent director.
pursuant to which he will be appointed Executive Vice President and Chief Financial Officer of the Company, effective May 5, 2025.
Bryan Castellani will step down as Executive Vice President and CFO, effective May 5, 2025.
each of Richard Chin, Derek Jensen, Speaker John Boehner, Martin Payne and Michael Noonen ceased to be a director of SKGR
each of Richard Chin, Derek Jensen, Speaker John Boehner, Martin Payne and Michael Noonen ceased to be a director of SKGR
Mr. Jensen resigned as Chief Financial Officer
Mr. Anquan Wang, Mr. Haichen Wang and Mr. Benjamin Worthy James will serve as directors of Merger Sub II, the Surviving Company.
Mr. Anquan Wang, Mr. Haichen Wang and Mr. Benjamin Worthy James will serve as directors of Merger Sub II, the Surviving Company.
each of Richard Chin, Derek Jensen, Speaker John Boehner, Martin Payne and Michael Noonen ceased to be a director of SKGR
Mr. Anquan Wang, Mr. Haichen Wang and Mr. Benjamin Worthy James will serve as directors of Merger Sub II, the Surviving Company.
each of Richard Chin, Derek Jensen, Speaker John Boehner, Martin Payne and Michael Noonen ceased to be a director of SKGR
each of Richard Chin, Derek Jensen, Speaker John Boehner, Martin Payne and Michael Noonen ceased to be a director of SKGR
Mr. Chin resigned as Chief Executive Officer
On April 13, 2025, Michael Geary was appointed to serve as Interim Chief Financial Officer of ClimateRock, effective immediately.
the Board appointed Denise W. Warren, current Chairman of the Board, as Interim Chief Executive Officer, to serve until the appointment of a new Chief Executive Officer of the Company.
The Board appointed Ms. Warren, Dawn L. Kussow, Executive Vice President and Chief Financial Officer of the Company, and Chad C. White, Executive Vice President, General Counsel and Secretary of the Company, to serve as members of the Office of the CEO (and designated each of Ms. Warren, Ms. Kussow and Mr. White as a principal executive officer of the Company), in each case, effective as of April 13, 2025.
The Board appointed Ms. Warren, Dawn L. Kussow, Executive Vice President and Chief Financial Officer of the Company, and Chad C. White, Executive Vice President, General Counsel and Secretary of the Company, to serve as members of the Office of the CEO (and designated each of Ms. Warren, Ms. Kussow and Mr. White as a principal executive officer of the Company), in each case, effective as of April 13, 2025.
On April 14, 2025, the Company announced that the board of directors of the Company (the “Board”) and Lucinda M. Baier, the Company’s President and Chief Executive Officer and member of the Board, mutually agreed that Ms. Baier’s role serving as the Company’s President and Chief Executive Officer and as a member of the Board would cease, effective as of April 13, 2025.
On April 11, 2025, the Board of Directors (the “Board”) of Butler National Corporation (the “Company”) was increased in size from 6 director positions to 7 and Julie M. Bowen was appointed to fill the newly created vacancy.
Mr. Wood’s employment with Adaptimmune Limited will end on August 31, 2025 (the “Revised Termination Date”) by reason of redundancy.
On April 8, 2025, HA Sustainable Infrastructure Capital, Inc. (the “Company”) announced the election of Barry E. Welch and Laura A. Schulte to become a new independent directors of the Company’s Board of Directors (the “Board”) effective April 15, 2025.
On April 8, 2025, HA Sustainable Infrastructure Capital, Inc. (the “Company”) announced the election of Barry E. Welch and Laura A. Schulte to become a new independent directors of the Company’s Board of Directors (the “Board”) effective April 15, 2025.
Richard Ziman, Chairman of the Board, will not stand for reelection at the 2025 annual meeting of stockholders (the “Annual Meeting”) as a result of Mr. Ziman’s decision to retire.
On April 10, 2025, Bruce Downey notified the Board of Directors (the “ Board ”) of C4 Therapeutics, Inc. (the “ Company ”) of his intention to retire from the Board and not to stand for reelection at the 2025 Annual Meeting of Stockholders.
On the same date, to fill the vacancy, the Board elected Sam Zheng Sun as a Director of the Company and Chairperson of the Board of Directors, as well as appointed Sam Zheng Sun as the Chief Executive Officer of the Company.
Effective April 14, 2025, Bian Fan was removed as Director, Chairperson of the Board of Directors and Chief Executive Officer of DT Cloud Star Acquisition Corporation (the “Company”) by the written consent of the board
On April 11, 2025, Richard Tarapchak was promoted and appointed as the Chief Financial Officer of the Company and its subsidiaries and was designated as the Company’s Principal Financial Officer.
On April 14, 2025, Verano Holdings Corp., a British Columbia corporation (the “ Company ”), announced that Brett Summerer resigned as Chief Financial Officer of the Company and from all officer and other positions with its subsidiaries.
On April 12, 2025, Stuart Diamond, a member of the board of directors (the “Board”) of bioAffinity Technologies, Inc., a Delaware corporation (the “Company”), notified the Company of his decision not to stand for re-election at the Company’s 2025 annual meeting of stockholders (the “2025 Annual Meeting”).
On April 10, 2025, the Board appointed Guoquan (Paul) Huang to serve on the board of directors, effective upon the closing of the Private Placement and the satisfactory completion of a background check, as a Class II director for a term expiring at the 2026 annual meeting of stockholders and until his successor is elected and qualified or until his earlier death, resignation or removal or as otherwise provided in the bylaws of the Company.
On April 11, 2025, the Board approved the appointment of Karen Dykstra as a director of the Company, effective as of April 14, 2025.
On April 9, 2025, Enrique Salem notified Atlassian Corporation (the “ Company ”) of his decision to retire as a director of the Company, effective as of April 14, 2025.
On April 8, 2025, Nixxy, Inc. (the “Company”) appointed Ashissh Raichura as a member of the Company’s Board of Directors (the “Board”).
appointed Ben C. Rodgers to the role of executive vice president and chief financial officer, effective as of May 12, 2025
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.